This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, B.
Right arrow Articles by Enders, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, B.
Right arrow Articles by Enders, G. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2001, p. 2755-2766, Vol. 21, No. 8
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.8.2755-2766.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

S and G2 Phase Roles for Cdk2 Revealed by Inducible Expression of a Dominant-Negative Mutant in Human Cells

Bing Hu,1,2,3 Jayashree Mitra,1,2,3 Sander van den Heuvel,4 and Greg H. Enders1,2,3,*

Departments of Medicine1 and Genetics2 and Cancer Center,3 University of Pennsylvania, Philadelphia, Pennsylvania, and Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts4

Received 8 November 2000/Accepted 17 January 2001

Cyclin-dependent kinase 2 (Cdk2) is essential for initiation of DNA synthesis in higher eukaryotes. Biochemical studies in Xenopus egg extracts and microinjection studies in human cells have suggested an additional function for Cdk2 in activation of Cdk1 and entry into mitosis. To further examine the role of Cdk2 in human cells, we generated stable clones with inducible expression of wild-type and dominant-negative forms of the enzyme (Cdk2-wt and Cdk2-dn, respectively). Both exogenous proteins associated efficiently with endogenous cyclins. Cdk2-wt had no apparent effect on the cell division cycle, whereas Cdk2-dn inhibited progression through several distinct stages. Cdk2-dn induction could arrest cells at the G1/S transition, as previously observed in transient expression studies. However, under normal culture conditions, Cdk2-dn induction primarily arrested cells with S and G2/M DNA contents. Several observations suggested that the latter cells were in G2 phase, prior to the onset of mitosis: these cells contained uncondensed chromosomes, low levels of cyclin B-associated kinase activity, and high levels of tyrosine-phosphorylated Cdk1. Furthermore, Cdk2-dn did not delay progression through mitosis upon release of cells from a nocodazole block. Although the G2 arrest imposed by Cdk2-dn was similar to that imposed by the DNA damage checkpoint, the former was distinguished by its resistance to caffeine. These findings provide evidence for essential functions of Cdk2 during S and G2 phases of the mammalian cell cycle.

* Corresponding author. Mailing address: Penn/GI Division, 600 CRB, 415 Curie Blvd., Philadelphia, PA 19104-6144. Phone: (215) 898-0159. Fax: (215) 573-2024. E-mail address: endersgh{at}mail.med.upenn.edu.

Molecular and Cellular Biology, April 2001, p. 2755-2766, Vol. 21, No. 8
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.8.2755-2766.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Boquoi, A., Chen, T., Enders, G. H. (2009). Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032. Cancer Prevention Research 2: 800-806 [Abstract] [Full Text]  
  • Byth, K. F., Thomas, A., Hughes, G., Forder, C., McGregor, A., Geh, C., Oakes, S., Green, C., Walker, M., Newcombe, N., Green, S., Growcott, J., Barker, A., Wilkinson, R. W. (2009). AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Molecular Cancer Therapeutics 8: 1856-1866 [Abstract] [Full Text]  
  • Scholz, A, Wagner, K, Welzel, M, Remlinger, F, Wiedenmann, B, Siemeister, G, Rosewicz, S, Detjen, K M (2009). The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Gut 58: 261-270 [Abstract] [Full Text]  
  • Fung, T. K., Ma, H. T., Poon, R. Y.C. (2007). Specialized Roles of the Two Mitotic Cyclins in Somatic Cells: Cyclin A as an Activator of M Phase-promoting Factor. Mol. Biol. Cell 18: 1861-1873 [Abstract] [Full Text]  
  • Cai, D., Latham, V. M. Jr., Zhang, X., Shapiro, G. I. (2006). Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells.. Cancer Res. 66: 9270-9280 [Abstract] [Full Text]  
  • Price, P. M., Yu, F., Kaldis, P., Aleem, E., Nowak, G., Safirstein, R. L., Megyesi, J. (2006). Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2. J. Am. Soc. Nephrol. 17: 2434-2442 [Abstract] [Full Text]  
  • Shapiro, G. I. (2006). Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment. JCO 24: 1770-1783 [Abstract] [Full Text]  
  • Byth, K. F., Geh, C., Forder, C. L., Oakes, S. E., Thomas, A. P. (2006). The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor.. Molecular Cancer Therapeutics 5: 655-664 [Abstract] [Full Text]  
  • Cai, D., Byth, K. F., Shapiro, G. I. (2006). AZ703, an Imidazo[1,2-a]Pyridine Inhibitor of Cyclin-Dependent Kinases 1 and 2, Induces E2F-1-Dependent Apoptosis Enhanced by Depletion of Cyclin-Dependent Kinase 9. Cancer Res. 66: 435-444 [Abstract] [Full Text]  
  • Crescenzi, E., Palumbo, G., Brady, H. J.M. (2005). Roscovitine Modulates DNA Repair and Senescence: Implications for Combination Chemotherapy. Clin. Cancer Res. 11: 8158-8171 [Abstract] [Full Text]  
  • Takahashi, T., Yamasaki, F., Sudo, T., Itamochi, H., Adachi, S., Tamamori-Adachi, M., Ueno, N. T. (2005). Cyclin A-associated kinase activity is needed for paclitaxel sensitivity. Molecular Cancer Therapeutics 4: 1039-1046 [Abstract] [Full Text]  
  • Raynaud, F. I., Whittaker, S. R., Fischer, P. M., McClue, S., Walton, M. I., Barrie, S. E., Garrett, M. D., Rogers, P., Clarke, S. J., Kelland, L. R., Valenti, M., Brunton, L., Eccles, S., Lane, D. P., Workman, P. (2005). In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202. Clin. Cancer Res. 11: 4875-4887 [Abstract] [Full Text]  
  • Carloni, V., Vizzutti, F., Pantaleo, P. (2005). Farnesyltransferase Inhibitor, ABT-100, Is a Potent Liver Cancer Chemopreventive Agent. Clin. Cancer Res. 11: 4266-4274 [Abstract] [Full Text]  
  • Dash, B. C., El-Deiry, W. S. (2005). Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity. Mol. Cell. Biol. 25: 3364-3387 [Abstract] [Full Text]  
  • Maude, S. L., Enders, G. H. (2005). Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response. Cancer Res. 65: 780-786 [Abstract] [Full Text]  
  • Zhu, Y., Alvarez, C., Doll, R., Kurata, H., Schebye, X. M., Parry, D., Lees, E. (2004). Intra-S-Phase Checkpoint Activation by Direct CDK2 Inhibition. Mol. Cell. Biol. 24: 6268-6277 [Abstract] [Full Text]  
  • Whittaker, S. R., Walton, M. I., Garrett, M. D., Workman, P. (2004). The Cyclin-dependent Kinase Inhibitor CYC202 (R-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase Pathway. Cancer Res. 64: 262-272 [Abstract] [Full Text]  
  • Jiang, J., Matranga, C. B., Cai, D., Latham, V. M. Jr., Zhang, X., Lowell, A. M., Martelli, F., Shapiro, G. I. (2003). Flavopiridol-Induced Apoptosis during S Phase Requires E2F-1 and Inhibition of Cyclin A-Dependent Kinase Activity. Cancer Res. 63: 7410-7422 [Abstract] [Full Text]  
  • Mazzocca, A., Giusti, S., Hamilton, A. D., Sebti, S. M., Pantaleo, P., Carloni, V. (2003). Growth Inhibition by the Farnesyltransferase Inhibitor FTI-277 Involves Bcl-2 Expression and Defective Association with Raf-1 in Liver Cancer Cell Lines. Mol. Pharmacol. 63: 159-166 [Abstract] [Full Text]  
  • Moore, J. D., Kornbluth, S., Hunt, T. (2002). Identification of the Nuclear Localization Signal in Xenopus Cyclin E and Analysis of Its Role in Replication and Mitosis. Mol. Biol. Cell 13: 4388-4400 [Abstract] [Full Text]  
  • Haq, R., Brenton, J. D., Takahashi, M., Finan, D., Rottapel, R., Zanke, B. (2002). Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence. Cancer Res. 62: 5076-5082 [Abstract] [Full Text]  
  • Zeng, H. (2002). Selenite and Selenomethionine Promote HL-60 Cell Cycle Progression. J. Nutr. 132: 674-679 [Abstract] [Full Text]  
  • Wu, C.-L., Kirley, S. D., Xiao, H., Chuang, Y., Chung, D. C., Zukerberg, L. R. (2001). Cables Enhances Cdk2 Tyrosine 15 Phosphorylation by Wee1, Inhibits Cell Growth, and Is Lost in Many Human Colon and Squamous Cancers. Cancer Res. 61: 7325-7332 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»